10-Q: inTEST Corporation Reports Second Quarter 2024 Results, Impacted by Semiconductor Market Weakness

inTEST Corporation's second quarter results show a slight revenue increase year-over-year, but a decrease in gross margin, influenced by the acquisition of Alfamation and a downturn in the semiconductor market.

Summary

• inTEST Corporation reported a revenue of $34.0 million for the second quarter of 2024, a 4% increase compared to $32.6 million in the same period of 2023.
• The acquisition of Alfamation contributed $9.7 million to the revenue in the second quarter of 2024.
• The company's gross margin decreased to 41% in Q2 2024 from 46% in Q2 2023, primarily due to changes in product mix and increased fixed operating costs.
• Operating expenses increased, with general and administrative expenses rising significantly due to the Alfamation acquisition.
• Net earnings for the quarter were $230,000, a substantial decrease from $2.8 million in the same quarter of the previous year.
• The company's backlog was approximately $47.7 million at the end of June 2024, compared to $44.6 million at the end of June 2023.
• The semiconductor market continues to be a significant factor, with a noted weakness in demand impacting the company's results.

Sentiment

Score: 4

Explanation: The document presents mixed results with a significant decrease in profitability and a material weakness in internal controls, offset by some revenue growth from acquisitions and a healthy backlog. The overall tone is cautious due to the semiconductor market downturn and the need for remediation of internal control issues.

Positives

• The acquisition of Alfamation has expanded inTEST's presence in the automotive, life sciences, and specialty consumer electronics markets.
• Alfamation contributed $9.7 million in revenue in Q2 2024.
• The company's backlog increased to $47.7 million at the end of June 2024.
• The company has extended the maturity date of its Term Note and revolving credit facility to May 2, 2031.

Negatives

• Gross margin decreased to 41% in Q2 2024 from 46% in Q2 2023.
• Net earnings decreased significantly to $230,000 in Q2 2024 from $2.8 million in Q2 2023.
• The semiconductor market's weakness continues to impact the company's performance.
• The company experienced a decrease in orders compared to the same period in 2023.
• The company's disclosure controls and procedures were deemed not effective due to a material weakness in internal control over financial reporting.

Risks

• The company is exposed to the cyclical nature of the semiconductor market, which can cause significant fluctuations in orders and revenue.
• The company relies on a relatively few number of customers for a significant portion of its sales.
• The company is exposed to the risk of obsolescence of its inventory depending on the mix of future business and technological changes within the markets that it serves.
• The company may not be able to successfully integrate any business it does acquire with its existing business.
• The company has identified a material weakness in its internal control over financial reporting.
• The ongoing war between Russia and Ukraine continues to contribute to global inflationary pressures and the availability of certain raw materials.
• The company has a sole source supplier of capacitors located in Israel, which could be impacted by the ongoing conflict.

Future Outlook

The company anticipates that its cash and cash equivalents, combined with borrowing capacity and operational cash flow, will be sufficient to support short-term working capital and other corporate requirements. The company also plans to pursue acquisition opportunities and fund them through a combination of cash, credit facility, or equity issuance.

Management Comments

• Management is focused on diversifying markets and reducing dependence on the semiconductor market.
• Management is working to mitigate supply chain risks by qualifying new vendors and increasing inventory.
• Management is developing a remediation plan to address the material weakness in internal control over financial reporting.

Industry Context

The report highlights the impact of the semiconductor market's cyclical downturn on inTEST's performance, which is consistent with broader industry trends. The company's diversification efforts into other markets like automotive and life sciences reflect a common strategy among companies seeking to reduce reliance on the volatile semiconductor sector.

Comparison to Industry Standards

• The decrease in gross margin from 46% to 41% suggests a potential underperformance compared to industry peers, especially those with more diversified product portfolios or stronger pricing power.
• The significant drop in net earnings from $2.8 million to $230,000 indicates a substantial impact from the semiconductor downturn and integration costs, which may be worse than some competitors.
• The company's backlog of $47.7 million is a positive sign, but its conversion to revenue will be critical for future performance.
• The company's reliance on a few major customers is a risk factor that is common in the industry, but inTEST's concentration may be higher than some of its peers.
• The company's acquisition of Alfamation is a strategic move to diversify, similar to other companies in the industry seeking to expand into new markets.

Stakeholder Impact

• Shareholders will be concerned about the decrease in profitability and the material weakness in internal controls.
• Employees may be affected by the company's efforts to reduce costs and improve efficiency.
• Customers may experience changes in product availability or pricing due to supply chain issues.
• Suppliers may be impacted by the company's efforts to diversify its supply chain.

Next Steps

• The company will continue to monitor the semiconductor market and adjust strategies as needed.
• The company will focus on integrating Alfamation and realizing synergies from the acquisition.
• The company will implement a remediation plan to address the material weakness in internal control over financial reporting.
• The company will continue to diversify its markets and product offerings.

Key Dates

Keywords

semiconductor, test equipment, Alfamation, acquisition, gross margin, net earnings, backlog, automotive, life sciences, internal control, supply chain